跳至主要内容
临床试验/TCTR20220527006
TCTR20220527006尚未招募4 期

Efficacy and safety of microneedling-assisted topical botulinum toxin A for the treatment of enlarged facial pores: a split-face randomized controlled trial

Department of Dermatology, Faculty of Medicine Siriraj Hospital0 个研究点目标入组 30 人开始时间: 2022年5月27日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 Years 至 50 Years(—)
性别
All

入选标准

  • participants with visible topographic enlarged facial pores confirmed by a dermatologist

排除标准

  • 1. photosensitive dermatoses, Skin malignancy, keloid, immunocompromised host, dermatitis or infection at the treatment area
  • 2. regular smoking
  • 3. Pregnancy and lactating woman first 3 months
  • 4. Cannot come back for follow up
  • 5. AHA, retinoic acid, or topical agents for acne scar within 6 months 6. Laser, RF within 3 months
  • 7. Systemic steroid, immunosuppressive agents within 6 months
  • 8. Oral isotretinoin within 12 months

研究者

发起方
Department of Dermatology, Faculty of Medicine Siriraj Hospital

相似试验